Matrix Metalloproteinase Responsive Nanoparticles for Synergistic Treatment of Colorectal Cancer via Simultaneous Anti-Angiogenesis and Chemotherapy. [electronic resource]
Producer: 20170605Description: 2943-2953 p. digitalISSN:- 1520-4812
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Camptothecin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Drug Liberation
- HT29 Cells -- drug effects
- Humans
- Male
- Matrix Metalloproteinase 2 -- metabolism
- Mice, Inbred BALB C
- Nanoparticles -- administration & dosage
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Photoacoustic Techniques -- methods
- Rats, Sprague-Dawley
- Sorafenib
- Tissue Distribution
- Tumor Microenvironment
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.